MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88

1. Benito-Villalvilla, C.
2. Cirauqui, C.
3. Diez-Rivero, C.M.
4. Casanovas, M.
5. Subiza, J.L.
6. Palomares, O.